vs

Side-by-side financial comparison of BARRETT BUSINESS SERVICES INC (BBSI) and SENSIENT TECHNOLOGIES CORP (SXT). Click either name above to swap in a different company.

SENSIENT TECHNOLOGIES CORP is the larger business by last-quarter revenue ($435.8M vs $321.1M, roughly 1.4× BARRETT BUSINESS SERVICES INC). SENSIENT TECHNOLOGIES CORP runs the higher net margin — 10.1% vs 5.1%, a 5.0% gap on every dollar of revenue. On growth, SENSIENT TECHNOLOGIES CORP posted the faster year-over-year revenue change (11.1% vs 5.3%). Over the past eight quarters, BARRETT BUSINESS SERVICES INC's revenue compounded faster (9.9% CAGR vs 3.9%).

Barrett Firearms Manufacturing is an Australian-owned, American manufacturer of firearms and ammunition located in Christiana, Tennessee. It was founded in 1982 by Ronnie G. Barrett for the purpose of building semi-automatic rifles chambered for the .50 BMG ammunition, originally developed for and used in M2 Browning machine guns. Barrett began this work in the early 1980s, and the first working rifles were available in 1982, hence the designation M82. Barrett personally designed every part o...

Sensient Technologies is a global manufacturer and marketer of colors, flavors and fragrances based in Milwaukee, Wisconsin. Their products are used in many foods and beverages, pharmaceuticals, cosmetics, home and personal care products, specialty printing and imaging products, computer imaging and industrial colors. Sensient reported revenue of $1,468 million in 2013. Subdivisions include the Sensient Flavors & Fragrances Group and the Sensient Color Group. Within the Flavors & Fragrances G...

BBSI vs SXT — Head-to-Head

Bigger by revenue
SXT
SXT
1.4× larger
SXT
$435.8M
$321.1M
BBSI
Growing faster (revenue YoY)
SXT
SXT
+5.7% gap
SXT
11.1%
5.3%
BBSI
Higher net margin
SXT
SXT
5.0% more per $
SXT
10.1%
5.1%
BBSI
Faster 2-yr revenue CAGR
BBSI
BBSI
Annualised
BBSI
9.9%
3.9%
SXT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BBSI
BBSI
SXT
SXT
Revenue
$321.1M
$435.8M
Net Profit
$16.4M
$44.2M
Gross Margin
21.3%
Operating Margin
5.8%
15.3%
Net Margin
5.1%
10.1%
Revenue YoY
5.3%
11.1%
Net Profit YoY
-2.4%
28.2%
EPS (diluted)
$0.63
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BBSI
BBSI
SXT
SXT
Q1 26
$435.8M
Q4 25
$321.1M
$393.4M
Q3 25
$318.9M
$412.1M
Q2 25
$307.7M
$414.2M
Q1 25
$292.6M
$392.3M
Q4 24
$304.8M
$376.4M
Q3 24
$294.3M
$392.6M
Q2 24
$279.7M
$403.5M
Net Profit
BBSI
BBSI
SXT
SXT
Q1 26
$44.2M
Q4 25
$16.4M
$25.5M
Q3 25
$20.6M
$37.0M
Q2 25
$18.5M
$37.6M
Q1 25
$-1.0M
$34.5M
Q4 24
$16.8M
$30.1M
Q3 24
$19.6M
$32.7M
Q2 24
$16.7M
$30.9M
Gross Margin
BBSI
BBSI
SXT
SXT
Q1 26
Q4 25
21.3%
31.4%
Q3 25
24.1%
34.3%
Q2 25
23.8%
34.5%
Q1 25
14.6%
33.6%
Q4 24
23.4%
31.7%
Q3 24
25.3%
33.2%
Q2 24
24.3%
32.4%
Operating Margin
BBSI
BBSI
SXT
SXT
Q1 26
15.3%
Q4 25
5.8%
9.7%
Q3 25
7.8%
14.0%
Q2 25
7.5%
13.9%
Q1 25
-1.4%
13.6%
Q4 24
6.8%
11.2%
Q3 24
8.0%
12.9%
Q2 24
7.3%
12.3%
Net Margin
BBSI
BBSI
SXT
SXT
Q1 26
10.1%
Q4 25
5.1%
6.5%
Q3 25
6.5%
9.0%
Q2 25
6.0%
9.1%
Q1 25
-0.3%
8.8%
Q4 24
5.5%
8.0%
Q3 24
6.7%
8.3%
Q2 24
6.0%
7.7%
EPS (diluted)
BBSI
BBSI
SXT
SXT
Q1 26
$1.04
Q4 25
$0.63
$0.60
Q3 25
$0.79
$0.87
Q2 25
$0.70
$0.88
Q1 25
$-0.04
$0.81
Q4 24
$0.63
$0.71
Q3 24
$0.74
$0.77
Q2 24
$0.62
$0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BBSI
BBSI
SXT
SXT
Cash + ST InvestmentsLiquidity on hand
$157.2M
$38.5M
Total DebtLower is stronger
$767.8M
Stockholders' EquityBook value
$241.0M
$1.2B
Total Assets
$779.1M
$2.3B
Debt / EquityLower = less leverage
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BBSI
BBSI
SXT
SXT
Q1 26
$38.5M
Q4 25
$157.2M
$36.5M
Q3 25
$109.8M
$42.7M
Q2 25
$90.4M
$56.7M
Q1 25
$99.1M
$32.6M
Q4 24
$121.9M
$26.6M
Q3 24
$14.4M
$37.0M
Q2 24
$40.3M
$30.3M
Total Debt
BBSI
BBSI
SXT
SXT
Q1 26
$767.8M
Q4 25
$709.2M
Q3 25
Q2 25
Q1 25
Q4 24
$613.5M
Q3 24
Q2 24
Stockholders' Equity
BBSI
BBSI
SXT
SXT
Q1 26
$1.2B
Q4 25
$241.0M
$1.2B
Q3 25
$240.1M
$1.2B
Q2 25
$225.8M
$1.2B
Q1 25
$213.4M
$1.1B
Q4 24
$221.4M
$1.1B
Q3 24
$215.4M
$1.1B
Q2 24
$199.0M
$1.1B
Total Assets
BBSI
BBSI
SXT
SXT
Q1 26
$2.3B
Q4 25
$779.1M
$2.2B
Q3 25
$777.9M
$2.2B
Q2 25
$713.6M
$2.2B
Q1 25
$778.6M
$2.1B
Q4 24
$745.5M
$2.0B
Q3 24
$725.8M
$2.0B
Q2 24
$688.6M
$2.0B
Debt / Equity
BBSI
BBSI
SXT
SXT
Q1 26
0.63×
Q4 25
0.59×
Q3 25
Q2 25
Q1 25
Q4 24
0.58×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BBSI
BBSI
SXT
SXT
Operating Cash FlowLast quarter
$76.1M
Free Cash FlowOCF − Capex
$70.6M
FCF MarginFCF / Revenue
22.0%
Capex IntensityCapex / Revenue
1.7%
Cash ConversionOCF / Net Profit
4.64×
TTM Free Cash FlowTrailing 4 quarters
$47.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BBSI
BBSI
SXT
SXT
Q1 26
Q4 25
$76.1M
$44.6M
Q3 25
$38.4M
$44.0M
Q2 25
$-53.8M
$48.3M
Q1 25
$5.2M
$-9.0M
Q4 24
$53.4M
$21.4M
Q3 24
$-935.0K
$76.8M
Q2 24
$-51.3M
$43.8M
Free Cash Flow
BBSI
BBSI
SXT
SXT
Q1 26
Q4 25
$70.6M
$12.9M
Q3 25
$34.1M
$24.2M
Q2 25
$-58.2M
$27.1M
Q1 25
$697.0K
$-25.8M
Q4 24
$50.2M
$-1.7M
Q3 24
$-4.2M
$63.6M
Q2 24
$-56.3M
$32.0M
FCF Margin
BBSI
BBSI
SXT
SXT
Q1 26
Q4 25
22.0%
3.3%
Q3 25
10.7%
5.9%
Q2 25
-18.9%
6.5%
Q1 25
0.2%
-6.6%
Q4 24
16.5%
-0.5%
Q3 24
-1.4%
16.2%
Q2 24
-20.1%
7.9%
Capex Intensity
BBSI
BBSI
SXT
SXT
Q1 26
Q4 25
1.7%
8.0%
Q3 25
1.4%
4.8%
Q2 25
1.4%
5.1%
Q1 25
1.5%
4.3%
Q4 24
1.0%
6.1%
Q3 24
1.1%
3.4%
Q2 24
1.8%
2.9%
Cash Conversion
BBSI
BBSI
SXT
SXT
Q1 26
Q4 25
4.64×
1.75×
Q3 25
1.86×
1.19×
Q2 25
-2.92×
1.28×
Q1 25
-0.26×
Q4 24
3.18×
0.71×
Q3 24
-0.05×
2.35×
Q2 24
-3.07×
1.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BBSI
BBSI

Professional Employer Services$303.6M95%
Staffing Services$17.6M5%

SXT
SXT

Segment breakdown not available.

Related Comparisons